Kuros Biosurgery AG, a Swiss developer of biomaterials, has topped up a CHF 15 million (€13.89 million) financing round that closed for the first time in August, with an additional CHF 5 million from undisclosed investors. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
